Sarah Lay
Family · Frankfort, KYNPI 1821709288
Payments from drug & device makers
Across 165 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$803
- Lilly USA, LLC$394
- AstraZeneca$260
- Teva Pharmaceuticals USA, Inc.$255
- Novo Nordisk$146
- Johnson & Johnson$137
- plus $954 from 19 others
What the payments were for
- Food & beverage$2,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $803 |
| Lilly USA, LLC | 30 | $394 |
| AstraZeneca | 15 | $260 |
| Teva Pharmaceuticals USA, Inc. | 9 | $255 |
| Novo Nordisk | 9 | $146 |
| Johnson & Johnson | 6 | $137 |
| GSK | 6 | $123 |
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Alkermes, Inc. | 4 | $91 |
| Amgen | 5 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Pfizer | 3 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Astellas Pharma US Inc | 2 | $33 |
| Boehringer Ingelheim | 2 | $32 |
| Exact Sciences | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Abiomed | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
How this compares
$2,949 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 18 | $33,686 |
| JardianceEmpagliflozin | 35 | $25,865 |
| FarxigaDapagliflozin Propanediol | 35 | $24,139 |
| OzempicSemaglutide | 13 | $18,633 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $9,249 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,298 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,505 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $641 |
| ValacyclovirValacyclovir Hcl | 12 | $507 |
| Ropinirole Hcl | 18 | $414 |
| Hydroxyzine Hcl | 24 | $399 |
| Potassium Chloride | 16 | $390 |
| Bisoprolol Fumarate | 21 | $388 |
| Pantoprazole Sodium | 19 | $349 |
| Montelukast Sodium | 32 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $803 | $33,68618 claims |
| AstraZenecaFarxiga, Symbicort | $260 | $27,43748 claims |
| Boehringer IngelheimJardiance | $32 | $25,86535 claims |
| Novo NordiskOzempic | $146 | $18,63313 claims |
| GSKAnoro Ellipta | $123 | $9,24912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Frankfort
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.